A native San Franciscan, Alicia chairs the firm’s pharmaceutical and medical device litigation group and served as the managing partner of the San Francisco office from 2005-2011. She has represented drug and device manufacturers for more than 30 years. Alicia currently serves as the firm’s Relationship Partner for Pfizer, Inc., Roche, and Genentech, for which she serves as national MDL counsel. Alicia represents these companies in mass tort litigation throughout the country. She also represents Bayer in various California litigations, including Mirena and Cipro. In 2006, she represented Philip Morris in a 10-week trial of a case brought by an individual smoker with lung cancer in which Philip Morris received a unanimous defense verdict.
Alicia has a broad range of litigation experience and is well-known to local judges, arbitrators and lawyers on both sides of the bar in multiple practice areas. Prior to joining Shook in 2000, Alicia was at Sedgwick, where she worked on a variety of drug and device cases, including acting as Regional Counsel for Bristol Myers Squibb, coordinating the defense of individual breast implant cases in 6 states: California, Nevada, Washington, Oregon, New Mexico, and Arizona. While at Sedgwick, Alicia tried five cases on behalf of the Dalkon Shield Claimants’ Trust. Early in her career and before joining Sedgwick, Alicia served as local counsel on the DES litigation in the San Francisco Bay Area.
Alicia has presented at the Defense Research Institute, the American Bar Association's Product Liability Section and Tort Trial and Insurance Practice Section, the American Society for Quality Biomedical Division, and the Diversity & Flexibility Alliance on numerous topics, including complex tort litigation, jury selection, punitive damages and deposition strategy.